Ottaiano A - Search Results

1

Cetuximab-dependent ADCC in cancer: dream or reality?

Ottaiano A, Scala S, Iaffaioli VR. Ottaiano A, et al. Cancer Immunol Immunother. 2010 Oct;59(10):1607-8; author reply 1609-10. doi: 10.1007/s00262-010-0884-3. Epub 2010 Jun 25. Cancer Immunol Immunother. 2010. PMID: 20577878 Free PMC article. No abstract available.

2

CD40 activation as potential tool in malignant neoplasms.

Ottaiano A, Pisano C, De Chiara A, Ascierto PA, Botti G, Barletta E, Apice G, Gridelli C, Iaffaioli VR. Ottaiano A, et al. Tumori. 2002 Sep-Oct;88(5):361-6. doi: 10.1177/030089160208800502. Tumori. 2002. PMID: 12487551 Review.

3

Neoadjuvant chemotherapy for intermediate/high-grade soft tissue sarcomas: five-year results with epirubicin and ifosfamide.

Ottaiano A, De Chiara A, Fazioli F, De Rosa V, Ravo V, Boccia V, Botti G, Petrillo A, Fiore F, Mori S, Mozzillo N, Iaffaioli VR, Apice G. Ottaiano A, et al. Anticancer Res. 2002 Nov-Dec;22(6B):3555-9. Anticancer Res. 2002. PMID: 12552955 Clinical Trial.

4

Pancreatic involvement from heavily pretreated small cell lung cancer successfully treated with transcatheter intra-arterial chemotherapy: a case report with local and systemic disease control.

Ottaiano A, Barletta E, Maione P, Fiore F, Pisano C, Di Maio M, Iaffaioli VR, Gridelli C. Ottaiano A, et al. Tumori. 2002 Nov-Dec;88(6):535-7. doi: 10.1177/030089160208800621. Tumori. 2002. PMID: 12597154

5

Safety of cisplatin after severe hypersensitivity reactions to carboplatin in patients with recurrent ovarian carcinoma.

Ottaiano A, Tambaro R, Greggi S, Prato R, Di Maio M, Esposito G, Scala F, Barletta E, Losito S, De Vivo R, Iaffaioli VR, Pignata S. Ottaiano A, et al. Anticancer Res. 2003 Jul-Aug;23(4):3465-8. Anticancer Res. 2003. PMID: 12926091 Clinical Trial.

6

Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells.

Ottaiano A, di Palma A, Napolitano M, Pisano C, Pignata S, Tatangelo F, Botti G, Acquaviva AM, Castello G, Ascierto PA, Iaffaioli RV, Scala S. Ottaiano A, et al. Cancer Immunol Immunother. 2005 Aug;54(8):781-91. doi: 10.1007/s00262-004-0636-3. Epub 2004 Dec 11. Cancer Immunol Immunother. 2005. PMID: 15592929 Free PMC article.

7

Prospective clinical trials of biotherapies in solid tumors: a 5-year survey.

Ottaiano A, Mollo E, Di Lorenzo G, Pisano C, Di Maio M, Barletta E, Pensabene M, Segati R, Bullian P, Nasti G, Bryce J, Scala S, Castello G, Ascierto PA. Ottaiano A, et al. Cancer Immunol Immunother. 2005 Jan;54(1):44-50. doi: 10.1007/s00262-004-0567-z. Cancer Immunol Immunother. 2005. PMID: 15693138 Free PMC article. Review.

8

Prognostic value of serum VEGF in melanoma patients: a pilot study.

Ascierto PA, Leonardi E, Ottaiano A, Napolitano M, Scala S, Castello G. Ascierto PA, et al. Among authors: ottaiano a. Anticancer Res. 2004 Nov-Dec;24(6):4255-8. Anticancer Res. 2004. PMID: 15736481 Free article.

9

Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.

Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P, Napolitano M, Franco R, Botti G, Castello G. Scala S, et al. Among authors: ottaiano a. Clin Cancer Res. 2005 Mar 1;11(5):1835-41. doi: 10.1158/1078-0432.CCR-04-1887. Clin Cancer Res. 2005. PMID: 15756007

10

Temozolomide and cisplatin in avdanced malignant melanoma.

Daponte A, Ascierto PA, Gravina A, Melucci M, Scala S, Ottaiano A, Simeone E, Palmieris G, Comella G. Daponte A, et al. Among authors: ottaiano a. Anticancer Res. 2005 Mar-Apr;25(2B):1441-7. Anticancer Res. 2005. PMID: 15865103 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page